Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors [Phase 1]
This ClinicalTrials.gov entry describes a Phase 1 study to determine a suitable dose of ASP5834 in adults with solid tumors, including non-s…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Prospective Observational Study of Changes in Cortisol Levels After Neoadjuvant Immunotherapy and Their Prognostic Value in Patients With NSCLC
This clinical trial update describes an observational study examining changes in cortisol levels after neoadjuvant immunotherapy in non-smal…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers [NA]
This clinical trial update describes a dyadic yoga intervention study to improve physical performance and quality of life in patients with s…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Met Non Small Cell Cancer Registry (MOMENT)
The MOMENT registry, sponsored by EMD Serono Research & Development Institute, collects data on MET-related non-small cell cancer and is cur…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Incentive Spirometry to Improve Outcomes in Lung Cancer Patients Undergoing Concurrent Chemotherapy and Radiation Therapy [NA]
Clinical trial update indicates recruitment is ongoing for a study assessing incentive spirometry to improve outcomes in lung cancer patient…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of NT-175 in Adult Subjects With Unresectable, Advanced, and/or Metastatic Solid Tumors That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation [Phase 1]
NT-175 is being studied in a Phase 1 trial enrolling adults with unresectable, advanced, or metastatic solid tumors positive for HLA-A*02:01…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer [Phase 2]
Update on a Phase 2 study of tislelizumab in combination with investigational agents for non-small cell lung cancer; the trial is currently …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment [NA]
This clinical trial update describes an online psychosocial intervention intended to improve social well-being and support for women with st…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Post-Market Registry of Transbronchial Cryo-assisted RFA During Routine Standard Bronchoscopic Tumor Stagng and Resection [NA]
A post-market registry study evaluating transbronchial cryo-assisted radiofrequency ablation during routine bronchoscopic tumor staging and …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer [Phase 2, Phase 3]
This update describes an ongoing Phase 2/Phase 3 clinical trial evaluating BNT327 in combination with chemotherapy and other investigational…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50% [Phase 2]
Phase 2 trial evaluating reduced-dose carboplatin-doublet chemotherapy plus cemiplimab versus cemiplimab alone in treatment-naive older and …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors [Phase 1]
This is a Phase 1 trial evaluating BGB-43395 alone or in combination for advanced breast cancer and other solid tumors. Recruitment is ongoi…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer [Phase 1]
BeOne Medicines reports a Phase 1 trial of BG-60366 in adults with EGFR-mutant non-small cell lung cancer. The study is currently active but…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Clinical Study to Assess the Efficacy of Adjuvant Immunotherapy With Cemiplimab in Patients With Surgically Removed Non-small Cell Lung Cancer Who Have Not Received Prior Chemotherapy [Phase 3]
Phase 3 study evaluating adjuvant cemiplimab therapy in patients with surgically removed non-small cell lung cancer who have not received pr…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV) [Phase 3]
Nuvation Bio is conducting a Phase 3 trial (TRUST-IV) of taletrectinib vs placebo as adjuvant therapy in ROS1-positive non-small cell lung c…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Pharmacogenomics IND EXEMPT SNP Clinical Trial - Alectinib and Single Nucleotide Polymorphisms [Phase 2, Phase 3]
A pharmacogenomics study evaluating how single nucleotide polymorphisms may influence Alectinib treatment in non-small cell lung cancer, con…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Addition of Hypofractionated High Dose Radiation in Oligometastatic Disease [Phase 3]
Phase 3 trial update on adding hypofractionated high-dose radiation for oligometastatic disease in non-small cell lung cancer; the study is …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC [Phase 3]
A Phase 3 clinical trial is assessing SHR-A2009 in combination with Aumolertinib versus Aumolertinib alone as first-line therapy for EGFR-mu…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Harvesting Cells for Experimental Cancer Treatments
An NCI-sponsored clinical trial update indicates enrollment by invitation for a cell-harvesting approach in experimental cancer therapies ac…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols
This clinical trial update describes biospecimen procurement for the Center for Immuno-Oncology immunotherapy protocols. It covers recruitin…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Continued Access Study for Participants Deriving Benefit in Pfizer-Sponsored Avelumab Parent Studies That Are Closing [Phase 3]
This trial update describes a continued access study for participants who benefit from Pfizer-sponsored avelumab parent studies that are clo…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Microwave Ablation Plus Tislelizumab and Docetaxel in Advanced NSCLC After First-Line Immunotherapy Failure [Phase 2]
A Phase II clinical trial is evaluating microwave ablation combined with tislelizumab and docetaxel for advanced non-small cell lung cancer …
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change [Phase 2]
A Phase 2 study is evaluating osimertinib for non-small cell lung cancer with EGFR exon 20 alterations; the trial is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of ZW251 in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial update notes a study of ZW251 in participants with advanced solid tumors, including hepatocellular carcinoma, non-small c…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Trilaciclib in Patients Receiving Sacituzumab Tirumotecan for EGFR-mutated, Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
Phase II clinical trial evaluating trilaciclib in combination with sacituzumab govitecan for EGFR-mutated advanced non-small cell lung cance…